Stock & Company Details
Halozyme Therapeutics Inc. $HALO
Price:
N/A
N/A
113M
$12B
52 Week High:
N/A
10 Day Average Volume:
N/A
32.82
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
HALO technical indicators
Latest Halozyme Therapeutics Inc. (HALO) indicator readings as of 2026-10-08.
HALO's 14-day RSI is 52.6, in neutral territory. ADX reads 24.3, sitting between trending and range-bound. MACD (12, 26, 9) is 1.35, above the zero line.
HALO backtested strategy results
How 4 rule-based strategies performed on Halozyme Therapeutics Inc. (HALO) over recent history, last backtested 2026-09-03. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +56.0% | 55% | 11 | -28.5% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +61.4% | 48% | 23 | -37.5% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | +56.8% | 45% | 31 | -19.9% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +48.6% | 60% | 35 | -36.3% |
Overview
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Finance Bot
Ask your questions
Start by typing a question below.
